The anti-HIV-1 activity of chloroquine

Journal of Clinical Virology

Volumn 20, Issue 3, 2001, Pages 131-135

  Savarino, A ^a   Gennero, L ^a   Sperber, K ^a   Boelaert, J R ^a  

^a General Hospital St Jan   (Belgium)

Author keywords

Antiretroviral treatment; Chloroquine; Developing world; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CHLOROQUINE; DEFEROXAMINE; DIDANOSINE; FREE RADICAL; GLYCOPROTEIN GP 120; HYDROXYCHLOROQUINE; HYDROXYUREA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE; VIRUS REPLICATION;

ANTI-HIV AGENTS; CHLOROQUINE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; HYDROXYCHLOROQUINE; VIRUS REPLICATION;

EID: 0035141602     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(00)00139-6     Document Type: Article

References (26)

1. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis
2. Desferrioxamine and HIV
3. Antiretroviral therapy
4. Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea
5. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens
6. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine
7. Inhibitors of human immunodeficiency virus integrase
8. Growth of Francisella tularensis LSV in macrophages: the acidic intracellular compartment provides essential iron required for growth
9. Uptake of chloroquine and hydroxychloroquine by human leukocytes in vitro: relationship to cellular concentrations during antirheumatic therapy
10. Chloroquine serum concentration and side effects
11. Low levels of deoxyribonucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type I replication
12. Chloroquine: mechanisms of HIV inhibition
13. Inhibition of HIV-1 Tat transactivation by quinacrine and chloroquine
14. Hydroxyurea and HIV: 5 years later-from antiviral to immuno-modulating efffects
15. Hydroxyurea: mechanisms of HIV-1 inhibition
16. Hydroxyurea as an inhibitor of human immunodeficiency virus type I replication
17. Effects of chloroquine on iron metabolism in a lymphocytic cell line
18. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis
19. Reduction and loss of the iron center in the reaction of the mouse ribonucleotide reductase with hydroxyurea
20. Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin
21. Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences?
22. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production
23. Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with HIV-1
24. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes
25. Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1
26. Inhibition of human immunodeficiency virus infectivity by chloroquine